Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Lung Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22
Search /vufind/Search2/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22
PubPharm (6.391)
1
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer : Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS : A Phase Ib/II Multicenter Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer : Phase I Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer : Development of an Enhanced Risk Stratification System for Patients With Hospital-diagnosed Advanced Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative : A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
177Lu-anti-PD-L1 sdAb in Metastatic Non-small Cell Lung Cancer : Phase 0/1 Study of the Safety and Tolerability of 177Lu-RAD204, a Lutetium-177 Radiolabelled Single Domain Antibody Against Programmed Cell Death-Ligand 1 in Patients With Metastatic Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer : Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing : A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors : A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND EXPANSION STUDY OF PF-07265028 AS A SINGLE AGENT AND IN COMBINATION WITH SASANLIMAB EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF PF-07265028 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[640]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Lung Neoplasms
Medienart
6.391
Aufsätze
6.391
E-Artikel
6.391
E-Ressourcen
Zeitschriftentitel
6.391
ClinicalTrials.gov
Thema
6.391
610
Lung Neoplasms
5.117
Study Type: Interventional
3.578
Carcinoma, Non-Small-Cell Lung
2.344
Recruitment Status: Completed
1.971
Phase: Phase 2
1.516
Recruitment Status: Recruiting
1.211
Study Type: Observational
768
Phase: Phase 1
732
Small Cell Lung Carcinoma
697
Recruitment Status: Terminated
676
Medical Condition: Lung Cancer
651
Phase: Phase 3
618
Recruitment Status: Active, not recruiting
539
Recruitment Status: Unknown status
418
Carcinoma
391
Recruitment Status: Not yet recruiting
361
Medical Condition: Non-small Cell Lung Cancer
284
Medical Condition: Non Small Cell Lung Cancer
277
Phase: Phase 1, Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.820
2020-
2.434
2010-2019
137
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6.391
Englisch
Haven't found what you're looking for?
Wird geladen...